[go: up one dir, main page]

MX2013009957A - Agente de control de endoparasitos. - Google Patents

Agente de control de endoparasitos.

Info

Publication number
MX2013009957A
MX2013009957A MX2013009957A MX2013009957A MX2013009957A MX 2013009957 A MX2013009957 A MX 2013009957A MX 2013009957 A MX2013009957 A MX 2013009957A MX 2013009957 A MX2013009957 A MX 2013009957A MX 2013009957 A MX2013009957 A MX 2013009957A
Authority
MX
Mexico
Prior art keywords
endoparasites
control agent
agent
endoparasite control
salts
Prior art date
Application number
MX2013009957A
Other languages
English (en)
Other versions
MX345339B (es
Inventor
Akiyuki Suwa
Kiyoshi Kita
Original Assignee
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo filed Critical Univ Tokyo
Publication of MX2013009957A publication Critical patent/MX2013009957A/es
Publication of MX345339B publication Critical patent/MX345339B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan un agente de control de endoparásitos que comprende un derivado de carboxamida representado por la fórmula general (I) (ver Fórmula) una de sus sales como un ingrediente activo y un método para controlar endoparásitos, que comprende la administración oral o parenteral del agente de control de endoparásitos.
MX2013009957A 2011-03-02 2012-03-01 Agente de control de endoparásitos. MX345339B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011045042 2011-03-02
PCT/JP2012/055190 WO2012118139A1 (ja) 2011-03-02 2012-03-01 内部寄生虫防除剤

Publications (2)

Publication Number Publication Date
MX2013009957A true MX2013009957A (es) 2013-12-06
MX345339B MX345339B (es) 2017-01-25

Family

ID=46758065

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009957A MX345339B (es) 2011-03-02 2012-03-01 Agente de control de endoparásitos.

Country Status (16)

Country Link
US (1) US9447042B2 (es)
EP (1) EP2682115B1 (es)
JP (1) JP5973989B2 (es)
KR (1) KR101856577B1 (es)
CN (2) CN103415288B (es)
AU (1) AU2012224015B2 (es)
BR (1) BR112013021337B1 (es)
CA (1) CA2828060C (es)
CL (1) CL2013002507A1 (es)
ES (1) ES2625990T3 (es)
MX (1) MX345339B (es)
PH (1) PH12013501809A1 (es)
RU (1) RU2596788C2 (es)
UA (1) UA114287C2 (es)
WO (1) WO2012118139A1 (es)
ZA (1) ZA201305979B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5398712B2 (ja) 2008-06-26 2014-01-29 眞一 金丸 鼓膜または外耳道再生剤
EP2773203A1 (en) 2011-11-02 2014-09-10 Bayer Intellectual Property GmbH Compounds with nematicidal activity
RU2014122035A (ru) 2011-11-02 2015-12-10 Байер Интеллектуэль Проперти Гмбх Соединения с нематоцидной активностью
US9040708B2 (en) * 2011-11-04 2015-05-26 Syngenta Limited Pesticidal compounds
WO2013076231A1 (de) * 2011-11-25 2013-05-30 Bayer Intellectual Property Gmbh Verwendung von fluopyram zur bekämpfung von endoparasiten
JP6126115B2 (ja) * 2011-11-25 2017-05-10 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 殺内部寄生生物剤としてのアリールカルボキサミド類及びヘタリールカルボキサミド類の使用
EP2891492B1 (en) * 2012-08-30 2022-11-09 The University of Tokyo Endoparasite control agent
IN2015MN00404A (es) * 2012-08-30 2015-09-04 Univ Tokyo
TWI598325B (zh) * 2012-10-12 2017-09-11 Ｈ 朗德貝克公司 苯甲醯胺類
TW201427947A (zh) 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
EP2730570A1 (de) * 2012-11-13 2014-05-14 Bayer CropScience AG Pyridyloxyalkylcarboxamide und deren Verwendung als Endoparasitizide und Nematizide
TW201507722A (zh) 2013-04-30 2015-03-01 Bayer Cropscience Ag 做為殺線蟲劑及殺體內寄生蟲劑的ｎ－（２－鹵素－２－苯乙基）－羧醯胺類
TWI646092B (zh) 2013-08-26 2019-01-01 拜耳作物科學股份有限公司 具有殺蟲活性之化合物
UY35772A (es) * 2013-10-14 2015-05-29 Bayer Cropscience Ag Nuevos compuestos plaguicidas
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
WO2015125824A1 (ja) 2014-02-18 2015-08-27 日産化学工業株式会社 アルキニルピリジン置換アミド化合物及び有害生物防除剤
AU2015224926B2 (en) * 2014-03-05 2019-07-18 Nihon Nohyaku Co., Ltd. Endoparasite control agent
MX374120B (es) * 2014-03-05 2025-03-05 Univ Tokyo Compuestos derivados de carboxamida y el uso de los mismos para controlar endoparásitos en mamíferos.
UY36196A (es) * 2014-07-25 2016-02-29 Bayer Animal Health Gmbh Compuestos para usar en el tratamiento antihelmíntico
CN107108469A (zh) * 2014-10-28 2017-08-29 拜耳动物保健有限责任公司 用于抗蠕虫治疗的化合物
WO2016066636A1 (en) * 2014-10-29 2016-05-06 Bayer Cropscience Aktiengesellschaft N-(2-halogen-2-phenethyl)carboxamides as fungicides
JP6826977B2 (ja) 2014-12-02 2021-02-10 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 有害生物防除剤としての二環式化合物
US11174325B2 (en) 2017-01-12 2021-11-16 Carnegie Mellon University Surfactant assisted formation of a catalyst complex for emulsion atom transfer radical polymerization processes
RU2673677C1 (ru) * 2017-10-17 2018-11-29 ФАНО России, Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") Средство для дезинвазии против цист букстонелл крупного рогатого скота
USD888149S1 (en) 2018-01-04 2020-06-23 Samsung Electronics Co., Ltd. Type font
US11472894B2 (en) 2018-07-23 2022-10-18 Carnegie Mellon University Enzyme-assisted ATRP procedures
WO2020028715A1 (en) 2018-08-01 2020-02-06 Russell Alan J Amino-reactive positively charged atrp initiators that maintain their positive charge during synthesis of biomacro-initiators
WO2022128746A1 (en) * 2020-12-14 2022-06-23 Elanco Tiergesundheit Ag Quinoline derivatives as endoparasiticides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358385A1 (fr) 1976-07-12 1978-02-10 Nihon Nohyaku Co Ltd Derives de l'anilide benzoique et fongicides contenant ces derives
JPS539739A (en) 1976-07-12 1978-01-28 Nippon Nohyaku Co Ltd #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
KR890006573A (ko) 1987-10-26 1989-06-14 메리 엔 터커 N-페닐알킬벤즈아미드 살진균제
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
GB9601128D0 (en) * 1995-08-11 1996-03-20 Pfizer Ltd Parasiticidal compounds
ES2281453T3 (es) 2000-12-20 2007-10-01 Novartis Ag Amidoacetonitrilos antiendoparasitarios.
AR037746A1 (es) 2001-12-06 2004-12-01 Novartis Ag Compuestos derivados de amidoacetonitrilo, un procedimiento para su preparacion, un procedimiento para la preparacion de compuestos intermediarios, una composicion para combatir parasitos, un procedimiento para combatir dichos parasitos, y el empleo de dichos derivados para la preparacion de una com
AU2003266316B2 (en) 2002-08-12 2007-10-25 Bayer S.A.S. Novel 2-pyridylethylbenzamide derivative
WO2007060162A1 (en) 2005-11-22 2007-05-31 Bayer Cropscience Sa New n-(1-methyl-2phenylethyl)benzamide derivatives
TWI435863B (zh) * 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
EP2041090A1 (en) 2006-07-06 2009-04-01 Bayer CropScience SA N- (4-pyridin-2-ylbutyl) benzamide derivatives and their use as fungicides
WO2008003746A1 (en) 2006-07-06 2008-01-10 Bayer Cropscience Sa N-(4-pyridin-2-ylbutyl) carboxamide derivatives, their process of preparation and their use as fungicides
CL2008000512A1 (es) 2007-02-22 2008-08-29 Bayer Cropscience Sa Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
US20100063155A1 (en) 2007-02-22 2010-03-11 Pierre-Yves Coqueron N-(3-phenylpropyl)benzamide derivatives
PT2132987E (pt) * 2007-04-12 2016-06-07 Nihon Nohyaku Co Ltd Composição de agente nematicida e método de utilização do mesma
US8324263B2 (en) 2007-07-26 2012-12-04 Syngenta Crop Protection, Llc Microbiocidally active carboxamides
GB0807140D0 (en) * 2008-04-18 2008-05-21 Syngenta Participations Ag Novel microbiocides
GB0904658D0 (en) 2009-03-18 2009-04-29 Syngenta Crop Protection Ag Novel microbiocides
PT2564703T (pt) * 2009-03-25 2016-09-29 Bayer Cropscience Ag Combinações de substâncias ativas nematicidas compreendendo fluopiram e ciazipir
WO2013076231A1 (de) 2011-11-25 2013-05-30 Bayer Intellectual Property Gmbh Verwendung von fluopyram zur bekämpfung von endoparasiten

Also Published As

Publication number Publication date
ZA201305979B (en) 2014-10-29
EP2682115A4 (en) 2014-11-26
PH12013501809A1 (en) 2013-10-14
KR101856577B1 (ko) 2018-05-10
JP5973989B2 (ja) 2016-08-23
MX345339B (es) 2017-01-25
NZ613343A (en) 2015-09-25
BR112013021337B1 (pt) 2019-09-03
KR20140011341A (ko) 2014-01-28
AU2012224015B2 (en) 2017-04-13
UA114287C2 (uk) 2017-05-25
CA2828060C (en) 2018-11-06
RU2596788C2 (ru) 2016-09-10
US20140088157A1 (en) 2014-03-27
JPWO2012118139A1 (ja) 2014-07-07
EP2682115B1 (en) 2017-04-19
CN103415288B (zh) 2018-04-03
CN108524480A (zh) 2018-09-14
WO2012118139A1 (ja) 2012-09-07
EP2682115A1 (en) 2014-01-08
CN103415288A (zh) 2013-11-27
CA2828060A1 (en) 2012-09-07
ES2625990T3 (es) 2017-07-21
AU2012224015A1 (en) 2013-09-26
RU2013144215A (ru) 2015-04-10
CL2013002507A1 (es) 2014-05-23
US9447042B2 (en) 2016-09-20
BR112013021337A2 (pt) 2016-11-01

Similar Documents

Publication Publication Date Title
MX2013009957A (es) Agente de control de endoparasitos.
UY34997A (es) Agente de control de endoparásitos y método para usarlo
UY34996A (es) Agente de control de endoparásitos
DK2970216T3 (da) Biarylamidforbindelser som kinaseinhibitorer
SV2016005137A (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
MX2016005394A (es) Compuestos derivados de piridilo biciclicos fusionados a anillo como inhibidores de fgfr4.
DOP2012000058A (es) Agente terapeutico para trastornos del estado de animo
ECSP14013199A (es) Compuestos para el tratamiento y profilaxis de la enfermedad del virus sincicial respiratorio
EA201591612A1 (ru) ПРИМЕНЕНИЕ ПИРАЗОЛПИРИМИДИНОВЫХ ПРОИЗВОДНЫХ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ, СВЯЗАННЫХ С PI3Kδ
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
CO7200281A2 (es) Composicion para control de enfermedades de plantas y aplicacion para la misma
CY1117163T1 (el) Ιμιδαζοπυριδαζινες ως αναστολεις κινασης ακτ
CO6910187A2 (es) Composiciones parasiticidas que comprenden un agente activo isoxazolina, sus métodos y usos
CO6781541A2 (es) Derivados glucósidos y usos de los mismos
CL2015001461A1 (es) Una formulación estabilizada de pemetrexed.
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
MX2021005052A (es) Oxiesteroles y métodos de uso de los mismos.
CU20160192A7 (es) Derivados de indano e indolina útiles como activadores de la guanilato ciclasa soluble
MX2014005342A (es) Inhibidores del virus de la hepatitis c.
CO7350640A2 (es) Compuestos diméricos
CR20120316A (es) Procesos para la fabricación de un agente farmacéuticamente activo
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
MX374383B (es) Derivados de carboxamida como inhibidores de smurf-1
DK3103453T3 (da) Medicinsk sammensætning omfattende heterocyklisk diamino-carboxamidforbindelse som aktiv bestanddel
DOP2012000056A (es) Agente terapeutico para trastornos de ansiedad

Legal Events

Date Code Title Description
FG Grant or registration